Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit

Group 1 - Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing potential first- or best-in-class therapies for autoimmune diseases and cancer [3] - The company will participate in a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on February 19, 2026, featuring CEO Nadim Ahmed and CMO Jeffrey Jones [1] - The fireside chat will be accessible via a webcast on the company's investor relations website [2] Group 2 - Cullinan Therapeutics leverages expertise in T cell engagers, which are established in oncology and are now being advanced into autoimmune diseases [3] - The company aims to deliver new standards of care for patients through a clinical-stage pipeline built on rigorous scientific approaches and purposeful innovation [3]